|
Home | Technology News Search Engine:
|
|
|
|
Home: Technology News:
|
|
|
(IT-NEWSWIRE.COM, September 16, 2015 ) Portland, OR --
About Hospital-acquired Diseases
Hospital-acquired diseases are also known as nosocomial infections that are acquired in hospitals and other healthcare facilities. These infections are classified only when a patient is admitted for reasons other than the infections and are caused by bacteria, fungi, parasites, or viruses. Most common types of hospital-acquired infections are SSIs, UTIs, bloodstream infections, pneumococcal infections, MRSA, and gastrointestinal illnesses. These infections appear between 48 hours and four days after a patient is admitted and are usually related to a treatment of procedure used to treat or diagnose the patient's initial illness or injury. Hospital-acquired Diseases are preventable through adherence to strict guidelines and less usage of invasive equipment that must be followed by healthcare professionals while caring for the patient.
The global hospital-acquired disease testing market to grow at a CAGR of 19.44% over the period 2014-2019.
Enquire about this report @ http://www.bigmarketresearch.com/report-enquiry/320979
Covered in this Report
In this report, Technavio covers the present scenario and the growth prospects of the global hospital-acquired disease testing market for the period 2015-2019. To calculate the market size, we consider revenue generated from the sales of testing products used in the following hospital-acquired disease infections: SSIs, UTIs, bloodstream infections, pneumococcal infections, MRSA, and other
Global Hospital-acquired Disease Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global hospital-acquired disease testing market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Abbott Laboratories
• Becton and Dickenson
• bioMerieux
• Roche Diagnostics
Other Prominent Vendor
• Akers Biosciences
• Alere
• Beckman Coulter/Danaher
• Cantel Medical
• Cepheid
• Diatherix Laboratories
• Eiken Chemical
• Enzo Biochem
• Fujirebio/Innogenetics
• Gen-Probe
• Humor Diagnostica
• Life Technologies
• Meridian Bioscience
• Nordion
• QIAGEN
Market Driver
• Rising Prevalence of HAIs
• For a full, detailed list, view our report
Market Challenge
• Lack of Healthcare Infrastructure
• For a full, detailed list, view our report
Market Trend
• Technological Advancements
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Contact Details:
James Jordan
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
Email: help@bigmarketresearch.com
Web: http://www.bigmarketresearch.com
Big Market Research
James Jordan
+ 1-503-894-6022
james@bigmarketresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
|
Technology News Headlines
|
|
|
|
|
Technology Business Video Feed
|
|
More Technology Video Feeds
|
|
|
